Following is a summary of current health news briefs.
J&J secures dismissal of whistleblower case over misuse of confidential info
A federal appeals court, in a decision unsealed Wednesday, upheld the dismissal of a whistleblower lawsuit against Johnson & Johnson as a sanction for the plaintiffs' misuse of confidential records they obtained through related litigation. The lawsuit, which accused J&J's DePuy Orthopaedics unit of defrauding the federal government by marketing defective hip implants, was dismissed in December 2021.
AstraZeneca to stop developing Crohn's disease drug
British drugmaker AstraZeneca said on Thursday it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative colitis. The company said the discontinuation was due to a delay in the drug's development timeline, affected by global events and "the context of a competitive landscape".
Tunisia's financial crisis leaves the sick struggling to find medicine
Sick Tunisians face a frantic struggle to find some medicines because the cash-strapped state has reduced imports, leaving doctors unable to control debilitating health problems and patients turning to informal markets for their medication. Hundreds of medicines have been missing for months, pharmacies say, including important treatments for heart disease, cancer and diabetes as well as more basic products such as medicated eye drops whose absence worsens chronic conditions.
...
Hyderabad: BRS leader Aedla Sudhakar Reddy strongly criticised the statements of HYDRAA commissioner A.V. Ranganath regarding the status of Bathukammakunta. The official had claimed that the place...